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Abstract
The substrate specificity of the rat mammary tissue high affinity, Naq-dependent anionic amino acid transport system has
been investigated using explants and the perfused mammary gland. D-Aspartate appears to be transported via the high
affinity, Naq-dependent L-glutamate carrier. Thus, D-aspartate transport by rat mammary tissue was Naq-dependent and
saturable with respect to extracellular D-aspartate with a K and V of 32.4 mM and 49.0 nmolr2 min per g of cellsm max
respectively. The uptake of D-aspartate by mammary explants was cis-inhibited by L-glutamate and L-aspartate, but not by
D-glutamate. L-glutamate uptake by mammary tissue explants was cis-inhibited by b-glutamate, L-cysteate, L-cysteine
sulfinate and dihydrokainate but not by DL-a-aminoadipate. In addition, dihydrokainate, but not DL-a-aminoadipate inhibited
D-aspartate and L-glutamate uptake by the perfused gland. D-Aspartate efflux from mammary tissue explants was
 .trans-accelerated by external L-glutamate in a dose-dependent fashion 50-500 mM . The effect of L-glutamate on
q D-aspartate efflux was dependent on the presence of extracellular Na . D-Aspartate, L-aspartate and L-cysteine sulfinate at
.500 mM also markedly trans-stimulated D-aspartate efflux from mammary tissue explants. In contrast, L-cysteine,
D-glutamate, L-leucine, dihydrokainate and DL-a-aminoadipate were either weak stimulators of D-aspartate efflux or were
without effect. D-Aspartate efflux from the perfused mammary gland was trans-stimulated by L-glutamate but not by
 .D-glutamate and only weakly by L-cysteine all at 500 mM . It appears that the mammary tissue high affinity anionic amino
acid carrier can operate in the exchange mode with a similar substrate specificity to that of the co-transport mode.
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1. Introduction
The lactating mammary epithelium has a large
demand for amino acids to meet the requirements of
milk protein synthesis. Amino acids are taken up by
mammary cells via a variety of individual transport
systems which have different substrate preferences
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and ionic requirements. For example, systems A,
ASC and L have been identified for neutral amino
acids and a system for cationic amino acid transport
w xhas also been described 1–5 . In addition, the lactat-
ing mammary gland also possesses an amino acid
transport system which is activated by cell-swelling
w xthat accepts taurine and glycine as substrates 6 .
We have recently studied the transport of L-
w xglutamate by the lactating mammary gland 7 . Our
interest in L-glutamate transport stems from the find-
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 .ings that L-glutamate is a the most abundant amino
 .acid in milk protein b is one of the most concen-
 .trated amino acids within mammary cells and c is,
depending on the species, concentrated in milk with
w xrespect to plasma 8 . Accordingly, the lactating
mammary gland has a high demand for L-glutamate
which is reflected, in a number of species, in large
arteriovenous L-glutamate concentration gradients
w xacross the mammary epithelium 9,10 . This is consis-
tent with the presence of a transport system for
L-glutamate in the lactating mammary gland and
suggests that mammary cells do not have to rely
w xsolely on L-glutamine as a source of L-glutamate 11 .
However, we must stress that we do not yet know the
exact contribution of the L-glutamate carrier to the
intracellular L-glutamate pool.
Rat mammary tissue expresses a high affinity,
q w x qNa -dependent L-glutamate carrier 7 . The Na -de-
pendent L-glutamate system, which appears to be
situated in the blood-facing pole of the mammary
epithelium, is the predominant, if not only, pathway
for L-glutamate uptake by rat mammary tissue. This
transport system appears, on the basis of cis-inhibi-
tion studies, to be selective for anionic amino acids,
thus, amino acids such as L- and D-aspartate markedly
reduced L-glutamate uptake by mammary tissue in a
high affinity fashion. In contrast, neutral and cationic
amino acids did not readily interact with the carrier
w x7 . The ability of the rat mammary L-glutamate
transport mechanism to discriminate between the L-
and D- isomers of glutamate but not those of aspartate
suggests that the carrier bears some resemblance to
the high affinity, Naq-dependent anionic amino acid
carriers which have been described in other tissues
such as the intestine, placenta, kidney and brain.
Indeed, several of the high affinity, Naq-dependent
L-glutamate transport systems, designated EAAC1,
GLAST, and GLT, have been cloned and their pri-
w xmary amino acid sequences determined 12–14 .
GLAST and GLT appear to be brain specific whereas
EAAC1 is expressed in both brain and peripheral
tissues.
The purpose of the present study was two-fold.
The first objective was to directly confirm that the
mammary tissue L-glutamate carrier accepts D-aspar-
tate which, on account of being non-metabolised,
would be an ideal substrate to further characterise the
mammary Naq-dependent anionic amino acid trans-
port system. Secondly, we wanted to further charac-
terise the substrate specificity and mechanistics of the
carrier which would allow us to compare the proper-
ties of the mammary system with those of other high
affinity, Naq-dependent acidic amino acid trans-
porters. Therefore, we have examined the transport of
L-glutamate and D-aspartate by isolated rat mammary
tissue explants and the perfused in situ rat mammary
gland. These two preparations are, in our opinion, the
two best experimental systems presently available to
w xstudy mammary amino acid transport 8 . Explants
allow transport systems to be rapidly identified and
characterised whereas the perfused mammary prepa-
ration allows conclusions to be drawn regarding the
location of the transport systems in the mammary
 .epithelium i.e. apical ˝ basolateral .
2. Materials and methods
2.1. Animals
Lactating Wistar rats 10–15 days post partum
were used. Animals were maintained on a 12 h
light–12 h dark cycle and allowed free access to
water and chow.
2.2. Preparation of mammary tissue explants
Mammary tissue explants were prepared according
w xto the method described in detail by Shennan 15 .
Rats were killed by cervical dislocation and the ab-
dominal mammary glands were immediately removed
and placed in an ice-cold buffer similar in composi-
tion to that required for the flux studies. The mam-
mary glands were finely dissected to produce ex-
plants weighing between 0.5–2.0 mg for the uptake
studies and 4.0–8.0 mg for the efflux experiments.
2.3. Measurement of L-glutamate and D-aspartate
transport in mammary tissue explants
2.3.1. L-Glutamate and D-aspartate uptake
L-Glutamate and D-aspartate uptake, respectively
w3 x w3 xusing L- H glutamate and D- H aspartate as tracers
was measured according to the methods described in
w xdetail by Millar et al. 7 . Briefly, tissue explants
were incubated in 4 or 6 ml of buffer compositions
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.given in figure and table legends at 378C for 20 min
 .prior to the addition of isotope 0.25–0.5 mCirml .
Following the addition of the radiolabel tissue ex-
plants were removed at pre-determined intervals and
immediately washed with 4 ml of an ice-cold buffer.
The tissue explants were lightly blotted and weighed.
Once the weight had been determined the tissue
explants were placed in 4 ml of either 10% trichloro-
 .acetic acid for the L-glutamate experiments or water
 .for the D-aspartate experiments and were allowed to
stand for at least 16 h. Afterwards the tubes were
centrifuged at 13 000=g for 3 min and a portion of
the resulting supernatant was counted to determine
the amount of isotope associated with the explants.
The specific activity of the radioisotopes in each
incubation medium was determined by counting the
radioactivity in 100 ml samples. The tissue extracel-
lular space was estimated in each experiment by
w3 xmeasuring the distribution of H sucrose between
the incubation medium and the tissue explants.
L-glutamate and D-aspartate uptake by tissue ex-
 .plants was calculated according to Eq. 1 :
amino acid s amino acid y amino acid .F 4 .c t m
r1yF 1 .
w xwhere amino acid is the cellular concentration ofc
wL-glutamate or D-aspartate in nmolrg of cells, amino
xacid is the total tissue concentration of L-glutamatet
wor D-aspartate in nmolrg of tissue wet weight, amino
xacid is the concentration of L-glutamate or D-m
aspartate in the incubation medium in nmolrml and
 .F is the sucrose space % .
2.3.2. D-Aspartate efflux
w3 xD-Aspartate efflux, using D- H aspartate as tracer,
was measured according to the method of Shennan
w x15 . Mammary tissue explants, prepared as described
above, were loaded with radiolabelled D-aspartate by
incubation at 208C for 30–40 min in a buffer contain-
 .ing mM 135 NaCl, 5 KCl, 2 CaCl , 1 MgSO , 102 4
glucose and 20 Tris-Mops, pH 7.4 q2–4 mCirml
w3 x .of D- H aspartate . Following the loading period the
tissue was transferred through a series of tubes con-
taining 2 ml of radioactive free solutions after which
the tissue was allowed to stand in 4.0 ml of distilled
water for at least 16 h in order to leach out the
 y1.remaining isotope. The fractional efflux min of
D-aspartate from the tissue explants was calculated
 .according to Eq. 2 :
Fractional effluxsDXrDtX 2 .t
 .where DX represents D-aspartate released dpm from
the tissue in the time interval Dt and X is the tissuet
 .D-aspartate content dpm at time t. The radioactivity
left in the tissue at a given time was determined by
adding the radioactivity left in the explant at the end
of the incubation to the radioactivity lost by the
explant in each of the collection periods in reverse
order.
We also analysed the D-aspartate efflux time
w xcourses by plotting ln radiolabelled D-aspartate re-
maining in the tissue as a function of time. The
negative slopes of these plots provided a measure of
 .the unidirectional efflux rate constants see Table 2 .
2.4. Perfusion of the lactating rat mammary gland
The lactating rat mammary gland was perfused
w xaccording to the method of Clegg and Calvert 16 .
Anaesthesia was induced and maintained throughout
the experiment by an intraperitoneal injection of
 .sodium pentobarbitone 40 mgrkg of body weight ,
and the tissue was perfused via the superficial epigas-
tric blood vessels see figure legends for precise
.composition of the perfusates . The perfusate was
delivered to the tissue with a flow and pressure
w xprofile similar to that in vivo 16 .
2.4.1. Measurement of L-glutamate and D-aspartate
uptake by the perfused gland
The transport of L-glutamate and D-aspartate, re-
w3 x w3 xspectively using L- H glutamate and D- H aspartate
as tracers, was measured using a rapid, paired-tracer
w xdilution technique as described by Millar et al. 7 . A
mixture containing the radiolabelled amino acid and
w14 x C sucrose was injected close arterially 60 ml in
.-2 s and 20 venous outflow samples were collected
 .at 6-s intervals. The uptake U of L-glutamate or
D-aspartate for each collection period was calculated
 .according to Eq. 3 :
U % s1y R rR 3 .  .  .t i
where R is the ratio of radiolabelled L-glutamate ort
.D-aspartate rradiolabelled sucrose in the venous out-
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flow samples at time t and R is the ratio of radiola-i
 .belled L-glutamate or D-aspartate rradiolabelled su-
 .crose in the injectate. The unidirectional uptake Vt
of L-glutamate and D-aspartate was calculated from
 .  .the maximum uptake U according to Eq. 4 :max
V syln 1yU =F=C 4 .  .t max
where F is the perfusate flow and C is the perfusate
concentration of unlabelled L-glutamate or D-aspar-
tate. The clearances of L-glutamate and D-aspartate
i.e., the volume of perfusate notionally cleared of
.isotope was calculated by multiplying the perfusate
 .  .flow rate mlrmin per g of tissue by the uptake %
for each collection period.
2.4.2. Measurement of D-aspartate efflux from the
perfused mammary gland
Mammary tissue, perfused as described above, was
loaded with radiolabelled D-aspartate by perfusing
 .with a buffer containing mM 118 NaCl, 4 KCl, 2
CaCl , 1 MgSO , 1 NaH PO , 25 NaHCO and 102 4 2 4 3
w3 xglucose plus 0.1–0.2 mCirml of D- H aspartate for
approximately 20 min. All perfusates were supple-
 .mented with BSA 5% wrv and gassed to pH 7.4
with 95% O r5% CO . Following the loading pe-2 2
riod, the mammary gland was perfused with solutions
free of radiolabelled aspartate see figure legends for
.details of composition and venous outflow samples
were collected at 2 min intervals. At the end of the
perfusion period the gland was removed and ho-
mogenised. Samples of the homogenate 150–250
.mg were incubated in distilled water for at least 16 h
in order to leach out the remaining isotope. The
amount of radioactivity associated with the ho-
mogenates was used to calculate the amount of iso-
tope remaining in the tissue at the end of the experi-
 .ment. Venous outflow samples 0.75 ml were mixed
with an equal volume of 10% TCA and were spun at
13 000=g for 3 min. 1 ml samples of the resulting
supernatants were removed and prepared for count-
 y1.ing. The fractional efflux min of D-aspartate from
the perfused gland was calculated according to Eq.
 .2 .
2.4.3. Materials
w3 x w3 xL- H Glutamate and D- H aspartate were pur-
 .chased from Amersham International UK . All other
 .chemicals were obtained from Sigma UK .
2.4.4. Statistics
Differences were assessed by Students’s paired or
unpaired t tests as appropriate and were considered
significant when P-0.05.
3. Results
3.1. D-Aspartate transport by mammary tissue ex-
plants and the perfused mammary gland
Cis inhibition studies of L-glutamate uptake by rat
mammary tissue suggest that D-aspartate is a sub-
w xstrate of the L-glutamate carrier 7 . If D-aspartate
does share a pathway for transport with L-glutamate
then it follows that D-aspartate transport should dis-
play similar characteristics to that of L-glutamate
transport. Thus, D-aspartate transport should be a
Naq-dependent process and should be inhibited by
amino acids that block L-glutamate uptake. Further-
more, Naq-dependent D-aspartate transport should be
situated in the basolateral pole of the mammary
w x qepithelium 7 . In view of this we tested the Na -de-
pendency of D-aspartate transport by mammary tissue
explants and the perfused mammary gland. In addi-
tion, we examined the effect of L-aspartate, L-gluta-
mate and D-glutamate on the clearance of D-aspartate
by the perfused mammary gland.
Fig. 1A shows that the uptake of D-aspartate mea-
.sured at a concentration of 5 mM by mammary
tissue explants was time dependent being linear for at
least 3 min. Fig. 1A also shows that D-aspartate
uptake by mammary explants was a Naq-dependent
process: replacing extracellular Naq with choline
ions abolished D-aspartate uptake. We tested the ef-
fect of reversing the Naq gradient on D-aspartate
efflux from mammary tissue explants preloaded with
radiolabelled D-aspartate. It was predicted that D-
aspartate efflux should be influenced by the extent of
the trans-membrane Naq gradient given that we have
previously shown that the mammary tissue L-gluta-
w xmate transporter can run in the reverse mode 7 .
Preliminary experiments revealed that D-aspartate ef-
flux, like that of L-glutamate, from mammary tissue
explants could be resolved into at least two compo-
 .nents results not shown . The fast component, which
was minimal by 20 min, represented the efflux of
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radiolabelled D-aspartate from the tissue extracellular
space. In view of this, we allowed the efflux of
D-aspartate to proceed for 40 min prior to testing the
effect of reversing the Naq-gradient. In this set of
 .  .Fig. 2. The effect of unlabelled ‘ L-aspartate, \ L-glutamate
 .and ^ D-glutamate on the clearance of D-aspartate by the
perfused rat mammary gland. The clearance in the absence of any
 .additions i.e. the control is shown by the open squares. The
 .perfusate contained mM 118 NaCl, 4 KCl, 2 CaCl , 12
NaH PO , 1 MgSO , 10 glucose and 25 NaHCO . The perfusate2 4 4 3
 .also contained BSA 5% and was gassed to pH 7.4 with 95%
O r5% CO . Each amino acid was added to the injectate at a2 2
concentration of 50 mM. The results shown are the mean"SEM
of 4 experiments.
experiments, the results of which are shown in Fig.
1B, we found that reversing the Naq-gradient by
transferring the tissue from a medium containing
Naq as the principal cation to one in which choline
had replaced Naq led to a marked increase in the
Fig. 1. A. The uptake of D-aspartate by rat mammary tissue
 .  .explants in the presence I and absence ^ of extracellular
q  .Na . Tissue was incubated in a medium containing mM 0.005
 .D-aspartate, 135 XCl where XsNa or choline , 5 KCl, 2
CaCl , 1 MgSO , 10 glucose and 20 Tris-Mops, pH 7.4. The2 4
results shown are the means"SEM of 3 experiments. B. The
effect of reversing the Naq-gradient on D-aspartate efflux from
rat mammary tissue explants. Tissue was first incubated in a
 .buffer containing mM 135 NaCl, 5 KCl, 2 CaCl , 1 MgSO , 102 4
glucose and 20 Tris-Mops, pH 7.4 followed by one of similar
q composition except that choline replaced the Na indicated by
.the bar . The results shown are the means"SEM of 5 experi-
ments. C. The clearance of D-aspartate by the perfused rat
 .  .mammary gland in the presence I and absence ^ of extra-
cellular Naq. The tissue was perfused with a buffer containing
 .  q q.mM 118 XCl where XsNa or NMDG , 4 KCl, 2 CaCl ,2
1 KH PO , 1 MgSO , 10 glucose and 20 Tris-Hepes, pH 7.4.2 4 4
 .The perfusate was supplemented with BSA 5% and gassed with
100% O . The results shown are the mean"SEM of 4 experi-2
ments.
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fractional release of D-aspartate. We found that D-
aspartate clearance by the perfused mammary gland
was a Naq-dependent process. Fig. 1C illustrates that
D-aspartate clearance by the perfused rat mammary
gland was markedly reduced when Naq was replaced
q  q .with NMDG suggesting that the Na -D-aspartate
cotransport mechanism is situated, along with Naq-
dependent L-glutamate transport, in the blood-facing
aspect of the mammary epithelium. We tested the
effect of unlabelled anionic amino acids on the clear-
ance of D-aspartate by the perfused mammary gland.
In this set of experiments the amino acids were
co-injected with the radiotracers. Although each
amino acid was present at a concentration of 50 mM
in the injectates it must be borne in mind that the
concentration of the amino acids at the site of trans-
port would have been much less owing to the diluting
effect of the perfusate. Fig. 2 shows that extracellular
L-glutamate and L-aspartate, but not D-glutamate, were
effective inhibitors of D-aspartate clearance by the
perfused mammary preparation. Importantly, the lack
of inhibition of D-aspartate clearance by D-glutamate
rules out the possibility that the other amino acids are
exerting their effect as a consequence of changing the
osmolality of the perfusate.These results taken to-
gether appear to confirm the prediction that D-aspar-
tate and L-glutamate are transported by a single car-
Fig. 3. The D-aspartate concentration dependence of D-aspartate
uptake by mammary tissue explants. Tissue was incubated in a
 .buffer containing mM 0.005–0.15 D-aspartate, 135 NaCl, 5
KCl, 2 CaCl 1 MgSO , 10 glucose and 20 Tris-Mops, pH 7.4.2, 4
D-Aspartate uptake was assayed at 378C after 2 min of incuba-
tion. The points shown are the mean"SEM of 3 experiments.
Table 1
The effect of a range of anionic amino acids on L-glutamate and
D-aspartate uptake by lactating rat mammary tissue explants
L-Glutamate uptake D-Aspartate uptake
 .Inhibitor IC mM50
L-Aspartate 40.6"0.7
D-Aspartate 15.9"8.6
D-Glutamate )1000
b-Glutamate 46.1"11.3
L-Cysteate 13.4"7.4
CSA 8.4"4.7
AAD )1000 )1000
DHK 17.5"6.1 42.1"8.7
 .Mammary tissue was incubated in a buffer containing mM
0.005 L-glutamate or D-aspartate, 135 NaCl, 5 KCl, 2 CaCl , 12
MgSO , 10 glucose and 20 Tris-Mops, pH 7.4 plus 5–1000 mM4
of the amino acids when required. Uptake was assayed after 2
min of incubation at 378C. The data for the effects of L-aspartate,
w xD-aspartate and D-glutamate on L-glutamate are taken from 7 .
rier in lactating rat mammary tissue and therefore
justify the use of D-aspartate to further characterise
the high affinity, Naq-dependent anionic amino acid
carrier which is expressed in mammary tissue.
3.2. The kinetic characteristics of D-aspartate uptake
by mammary tissue explants
 .The kinetic parameters i.e. K and V ofm max
D-aspartate uptake by lactating rat mammary tissue
explants were examined. Fig. 3 shows that D-aspar-
tate uptake was saturable with respect to the extracel-
lular D-aspartate concentration. The calculated Km
 .and V from Hanes-Woolf plots were respectivelymax
32.4"5.0 mM and 49.0"9.1 nmolr2 min per g of
 .cells "SEM, ns3 .
3.3. The effect of other anionic amino acids on
L-glutamate and D-aspartate transport
To gain more information on the substrate speci-
ficity of the carrier with respect to anionic amino
acids, we tested the effect of several other anionic
amino acids on L-glutamate and D-aspartate uptake by
both mammary explants and the perfused mammary
preparation. The amino acids tested were b-gluta-
mate and the sulfur containing amino acids L-cysteate
and L-cysteine sulfinate. In addition, we also exam-
 .ined the effect of DL-a-aminoadipate AAD and
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 .dihydrokainate DHK both of which have been
widely used to characterize L-glutamate transport in
 w x.other cell types e.g. see 17 . Table 1 shows the
effect of these amino acids on L-glutamate uptake by
mammary tissue explants. The IC for each amino50
 .Fig. 4. The effect of dihydrokainate \ and DL-a-aminoadipate
 .  .  .^ on the clearance of A D-aspartate and B L-glutamate by
the perfused rat mammary gland. The control clearance i.e. no
.additions of D-aspartate and L-glutamate is shown by the open
 .squares. The perfusate contained mM 0.001 D-aspartate or
L-glutamate, 118 NaCl, 4 KCl, 2CaCl , 1 MgSO , 1 NaH PO ,2 4 2 4
10 glucose and 25 NaHCO . The perfusate also contained BSA3
 .5% and was gassed to pH 7.4 with 95% O r5% CO . When2 2
required, DHK and AAD were added to the perfusate to give a
final concentration of 300 mM for the D-aspartate experiments
and 100 mM for the L-glutamate studies. The insets show the
effects of DHK and AAD on the unidirectional uptakes of
D-aspartate and L-glutamate. The results shown are means"SEM
of 5 and 3 experiments for L-glutamate and D-aspartate, respec-
tively. )) P -0.01; ))) P -0.001.
Fig. 5. The effect of extracellular L-glutamate on D-aspartate
efflux from rat mammary tissue explant. D-Aspartate efflux was
 .first measured into a medium containing mM 135 NaCl, 5 KCl,
2 CaCl , 1 MgSO , 10 glucose and 20 Tris-Mops, pH 7.42 4
 .followed by one of similar composition supplemented with B
 .  .  .50 mM, ’ 100 mM, % 200 mM or v 500 mM L-gluta-
 .mate indicated by bar . The results shown are means"SEM of 5
experiments.
w xacid was calculated from plots of J rJ yJ ˝1rIc c i
where J is the uptake in the absence of the inhibitor,c
J is the uptake in the presence of the inhibitor and Ii
is the concentration of inhibitor. Shown for compari-
son is the effect of L- and D-aspartate and D-glutamate
on L-glutamate uptake. All of the amino acids tested,
with the exception of AAD, inhibited L-glutamate
uptake with high affinity in a dose dependent fashion.
Table 1 shows that DHK also inhibited D-aspartate
uptake with high affinity. In contrast AAD had no
effect on D-aspartate uptake. Consistent with these
results was the finding that DHK, but not AAD,
inhibited D-aspartate and L-glutamate uptake by the
 .perfused mammary gland Fig. 4 .
3.4. The effect of extracellular amino acids on D-
aspartate efflux.
w xKanner and Bendahan 18 found that the efflux of
L-glutamate from synaptic plasma membrane vesicles
could be stimulated by external L-glutamate. Re-
w xcently, Zerangue and Kavanaugh 19 have shown
that a neuronal subtype Naq-dependent L-glutamate
 .transporter designated EAAT3 can transport anionic
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Table 2
 .The effect of external amino acids at 500 mM on D-aspartate
efflux from lactating rat mammary tissue explants
y1 y4 .Efflux rate constants min P10
Amino acid n control qtest difference P -
L-Glutamate 7 75"10 362"32 287"38 0.001
L-Aspartate 6 82"12 311"32 229"43 0.01
D-Aspartate 4 86"8 415"32 329"36 0.01
CSA 4 58"18 369"55 311"70 0.05
L-Cysteine 5 103"9 161"14 58"9 0.01
L-Leucine 3 80"12 88"23 8"11 n.s
D-Glutamate 5 87"20 105"19 18"9 n.s
DHK 4 54"11 100"14 46"3 0.001
AAD 3 73"16 87"22 14"9 n.s.
 .D-Aspartate efflux was measured into a medium containing mM
135 NaCl, 5 KCl, 2 CaCl , 1 MgSO , 10 glucose and 202 4
Tris-Mops, pH 7.4, and then to a similar medium supplemented
 .with a ‘test’ amino acid at 500 mM CSA sL-cysteine sulfinate .
amino acids by heteroexchange. These findings led us
to test whether the mammary anionic amino acid
transport mechanism can also function in the ex-
change mode. We tested the effect of a range of
extracellular amino acids on D-aspartate efflux from
mammary tissue explants. We chose D-aspartate in
preference to L-glutamate since the former is more
Fig. 6. The effect of extracellular L-glutamate on D-aspartate
efflux from mammary tissue explants in the presence and absence
of extracellular Naq. D-Aspartate was first measured into a
 .  q  .medium containing mM 135 XCl where XsNa B , Choline
 . q  ..v or Li ’ , 5 KCl, 2 CaCl , 1 MgSO , 10 glucose and 202 4
Tris-Mops, pH 7.4 followed by one of similar composition except
that it also contained 500 mM L-glutamate. The results shown are
the means"SEM of 4 experiments.
resistant to metabolism. For this set of experiments
the efflux of D-aspartate was initially measured into
an amino acid free medium and following this the
tissue was transferred into a medium supplemented
with a test amino acid. Fig. 5 shows that extracellular
L-glutamate trans-stimulated D-aspartate efflux from
rat mammary tissue explants in a dose-dependent
manner: this is consistent with heteroexchange. We
also examined the effect of D-glutamate, D-aspartate,
L-aspartate, L-cysteine, L-leucine, L-cysteine sulfinate,
Fig. 7. A,B. The effect of extracellular L-cysteine, D- and L-
glutamate on D-aspartate efflux from the perfused lactating rat
mammary gland. The gland was initially perfused with a buffer
 .containing mM 118 NaCl, 4 KCl, 2 CaCl , 1 MgSO , 12 4
NaH PO , 10 glucose and 25 NaHCO supplemented with BSA2 4 3
 . .5% and gassed to pH 7.4 with 95% O r5% CO followed by2 2
one of similar composition except that it contained L-cysteine,
 .  .D-glutamate or L-glutamate 500 mM as indicated by bars . The
results shown are the mean"SEM of 3 experiments.
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AAD and DHK on D-aspartate efflux from mammary
 .explants Table 2 . The results show that D-aspartate,
L-aspartate and L-cysteine sulfinate were as effective
as L-glutamate at trans-accelerating D-aspartate ef-
flux. On the other hand, L-cysteine and DHK only
weakly interacted with the carrier whilst D-glutamate,
L-leucine and AAD had no effect. The effect of
extracellular L-glutamate on D-aspartate efflux was
dependent upon extracellular Naq . Thus, L-glutamate
had no effect on D-aspartate efflux when extracellular
q q  .Na was replaced with either choline or Li Fig. 6 .
Note from Fig. 6 that the fractional efflux of D-
aspartate, in the absence of extracellular L-glutamate,
was higher when the medium was Naq-free. This is a
consequence of reversing the Naq-gradient and is
consistent with the results shown in Fig. 1B.
We also examined the effect of extracellular amino
acids on the efflux of radiolabelled D-aspartate from
the perfused lactating rat mammary gland to confirm
that the exchange of amino acids was occuring at the
basolateral aspect of the mammary epithelium. As
w3 xwith explants, the release of D- H aspartate from the
gland was initially high as a consequence of efflux
from the extracellular compartment. Therefore, the
efflux of D-aspartate was allowed to proceed for 40
min prior to testing the effect of extracellular amino
 .acids. Fig. 7 A and B shows that extracellular L-
glutamate, but not D-glutamate or L-cysteine,
markedly trans-accelerated D-aspartate efflux from
the perfused lactating rat mammary gland when tested
at a concentration of 500 mM.
4. Discussion
The first objective of this study was to confirm
that D-aspartate was transported by the mammary
tissue high affinity, Naq-dependent L-glutamate car-
rier. We did this because D-aspartate would be an
excellent substrate to further characterise mammary
tissue anionic amino acid transport, particularly ef-
flux, on account of being non-metabolized. The re-
sults of the present study confirm the prediction,
w xbased on cis-inhibition experiments 7 , that D-aspar-
tate is transported by the mammary tissue L-gluta-
mate carrier which is situated in the blood-facing
aspect of the mammary epithelium. Thus, D-aspartate
transport by mammary tissue is a Naq-dependent
process and is inhibited by L-glutamate and other
amino acids which inhibit L-glutamate transport. Sim-
ilarly, D-aspartate transport, like L-glutamate trans-
port, was insensitive to D-glutamate. The uptake of
D-aspartate by mammary tissue explants was sat-
urable with a K of 32.4 mM. Therefore, it appearsm
that the mammary anionic amino acid carrier has a
higher affinity for D-aspartate than L-glutamate given
that we have previously shown that the K form
w xL-glutamate by mammary explants is 112.5 mM 7 .
Importantly, the Naq-dependent system appears to be
the main, if not only, route for D-aspartate transport
in mammary tissue. There was, however, a difference
between the profiles of D-aspartate and L-glutamate
transport by the perfused mammary gland. Thus, the
clearance of D-aspartate, unlike that of L-glutamate,
did not decrease in the latter stages of the time
course. This may reflect that D-aspartate is more
avidly retained than L-glutamate by mammary tissue.
Thus, L-glutamate may exit mammary tissue via other
transport pathways. On the other hand, it may reflect
that D-aspartate is not metabolised. The mammary
tissue anionic amino acid transport system, which
bears many of the characteristics of high affinity,
Naq-dependent anionic amino acids transport systems
 - .system X described in other epithelia, also ap-AG
peared to interact with the sulfur containing amino
acids L-cysteate and L-cysteine sulfinate. We also
examined the effect of two other anionic amino acids,
namely AAD and DHK. We found that L-glutamate
and D-aspartate accumulation was inhibited by DHK
but not AAD. This profile of inhibition has not been
seen with other high affinity, Naq-dependent anionic
amino acid transport systems. For example, EAAC1
w xis inhibited by AAD but not DHK 17 , GLT-1 is
sensitive to both AAD and DHK whereas GLAST is
w xnot inhibited by either drug 17,20 .
High affinity, Naq-dependent anionic amino acid
carriers can operate in the exchange mode. For exam-
ple, it has recently been shown that external L-
glutamate can stimulate D-aspartate efflux via a high
affinity neuronal L-glutamate transporter expressed in
w xXenopus oocytes. 19 . It is apparent that L-glutamate
is capable of stimulating D-aspartate efflux from
mammary tissue explants. The question is: is the
trans-stimulation of D-aspartate efflux via the high
affinity, Naq-dependent carrier or via another sys-
tem? The finding that trans-stimulation of D-aspartate
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efflux by L-glutamate was dependent upon the pres-
ence of extracellular Naq is consistent with the ex-
change mode being a function of the high affinity,
Naq-dependent system. Moreover, the Naq-depen-
dence rules out system xy, a mechanism which isc
w xcapable of exchanging L-glutamate and L-cystine 21 .
In addition, it is evident from the experiments using
the perfused mammary preparation that the site of
amino acid exchange, like that of the cotransporter, is
in the blood-facing aspect of the epithelium. Our
results show that D-aspartate efflux from mammary
tissue can also be markedly trans-accelerated by
amino acids such as D-aspartate, L-aspartate and L-cy-
steine sulfinate. The finding that an amino acid can
trans-accelerate the efflux of D-aspartate suggests that
the particular amino acid is actually transported by
the carrier. Trans-stimulation of D-aspartate efflux by
L-glutamate, L-aspartate and L-cysteine sulfinate is
therefore consistent with their effects on L-glutamate
uptake by mammary tissue. In this connection, Bou-
w xvier et al. 22 , have shown that L-cysteine sulfinate is
transported by the L-glutamate carrier which is ex-
pressed in Muller cells from the salamander retina.
Interestingly, amino acids such as D-glutamate, AAD,
L-cysteine and L-leucine, which do not readily inter-
act with the mammary tissue Naq-dependent, anionic
amino acid cotransporter do not, or only weakly,
elicit trans-stimulation of D-aspartate efflux suggest-
ing that the exchange mode of the carrier has a
substrate specificity similar to that of the cotransport
mode. However, we found that DHK, which inhibits
the uptake of L-glutamate and D-aspartate, did not
markedly stimulate the efflux of D-aspartate. This
suggests that DHK, whilst binding to the carrier, is
not readily transported. The intracellular concentra-
tions of L-glutamate and L-aspartate and possibly
.other anionic amino acids in mammary tissue may
be regulated by the anionic amino acid transport
system working in the exchange mode as well as the
cotransport mode. For example, L-glutamate uptake
may influence the intracellular concentration of L-
 .aspartate and vice versa . In support of this notion is
the observation that D-aspartate efflux from mam-
mary tissue explants was stimulated by physiological
levels of extracellular L-glutamate. It is apparent from
this study that examining the effect of extracellular
amino acids on the efflux of D-aspartate is a rapid and
convenient way of testing whether an amino acid is
actually transported by the high affinity Naq-depen-
dent anionic amino acid carrier. This would be useful
particularly when the putative substrate is not readily
available in the radiolabelled form.
Finally, the observation that L-cysteine did not
readily stimulate D-aspartate efflux from mammary
tissue to the same extent as L-glutamate is worthy of
w xfurther comment. Zerangue and Kavanaugh 19 found
that L-cysteine was as capable as L-glutamate at
accelerating D-aspartate efflux via EAAT3, a human
homologue of EAAC1, expressed in Xenopus
oocytes. In contrast, L-cysteine did not readily inter-
act with the human homologues of GLAST and GLT.
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